Winston Vetharoy

1.1k total citations
7 papers, 108 citations indexed

About

Winston Vetharoy is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Winston Vetharoy has authored 7 papers receiving a total of 108 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Winston Vetharoy's work include CAR-T cell therapy research (5 papers), Virus-based gene therapy research (4 papers) and CRISPR and Genetic Engineering (3 papers). Winston Vetharoy is often cited by papers focused on CAR-T cell therapy research (5 papers), Virus-based gene therapy research (4 papers) and CRISPR and Genetic Engineering (3 papers). Winston Vetharoy collaborates with scholars based in United Kingdom, Germany and Greece. Winston Vetharoy's co-authors include Adrian J. Thrasher, Giorgia Santilli, Alessia Cavazza, Geoffroy Andrieux, Diego León‐Rico, Elizabeth Rivers, Dariusz Ładoń, Giandomenico Turchiano, Fang Zhang and Asma Naseem and has published in prestigious journals such as Nature Communications, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Winston Vetharoy

7 papers receiving 108 citations

Peers

Countries citing papers authored by Winston Vetharoy

Since Specialization

Citations

This map shows the geographic impact of Winston Vetharoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winston Vetharoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winston Vetharoy more than expected).

Fields of papers citing papers by Winston Vetharoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winston Vetharoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winston Vetharoy. The network helps show where Winston Vetharoy may publish in the future.

Co-authorship network of co-authors of Winston Vetharoy

This figure shows the co-authorship network connecting the top 25 collaborators of Winston Vetharoy. A scholar is included among the top collaborators of Winston Vetharoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winston Vetharoy. Winston Vetharoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia 2024 ·Journal of Allergy and Clinical Immunology ·(unknown), (unknown), (unknown), Thomas E. Whittaker, (unknown), Asma Naseem, Elena Blanco, Winston Vetharoy, (unknown), (unknown), (unknown), (unknown), Siobhan O. Burns, Emma Morris, Claire Booth, Giandomenico Turchiano, Alessia Cavazza, Adrian J. Thrasher, Giorgia Santilli	3
2	Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant 2024 ·Molecular Therapy ·Jenny Yeung, Aiyin Liao, (unknown), (unknown), Winston Vetharoy, (unknown), Ian Kirby, Francesca Zammarchi, Karin Havenith, (unknown), Patrick H. van Berkel, Neil J. Sebire, Olumide Ogunbiyi, Claire Booth, (unknown), Adrian J. Thrasher, Kerry Chester, Persis Amrolia	6
3	An improved medium formulation for efficient ex vivo gene editing, expansion and engraftment of hematopoietic stem and progenitor cells 2023 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Asma Naseem, Winston Vetharoy, (unknown), Adrian J. Thrasher, Giorgia Santilli, Alessia Cavazza	7
4	Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47 ^phox -Deficient Chronic Granulomatous Disease 2021 ·Human Gene Therapy ·(unknown), Winston Vetharoy, Uimook Choi, Christine Rivat, Narda Theobald, (unknown), Diego León‐Rico, Karen Buckland, Elena Armenteros-Monterroso, Sara Benedetti, Michael T. Ashworth, Michael Rothe, Axel Schambach, H. Bobby Gaspar, Elizabeth M. Kang, Harry L. Malech, Adrian J. Thrasher, Giorgia Santilli	4
5	Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome 2020 ·Nature Communications ·(unknown), (unknown), Elizabeth Rivers, Giandomenico Turchiano, (unknown), Winston Vetharoy, Dariusz Ładoń, Geoffroy Andrieux, Fang Zhang, (unknown), Diego León‐Rico, Giorgia Santilli, Adrian J. Thrasher, Alessia Cavazza	84
6	Construction and Pre-Clinical Evaluation of a New Anti-CD19 Chimeric Antigen Receptor 2016 ·Blood ·Anne Marijn Kramer, Sara Ghorashian, Gordon Weng-Kit Cheung, Winston Vetharoy, Dale Moulding, Leila Mekkaoui, Shimobi Onuoha, Persis Amrolia, Martin Pulé	3
7	Analysis Of T Cell Receptor Repertoire Reveals Evidence For Antigen-Specific Response In CLL Lymph Nodes 2013 ·Blood ·Marta Pasikowska, Deborah Yallop, William Townsend, Winston Vetharoy, Kirsty Cuthill, Timothy Tree, Andrea G.S. Buggins, Stephen Devereux	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact